AI Bias Analysis
4 models · Takes ~15 seconds
With good results from Intellia, the CRISPR field faces the question: How attractive will the one-and-done approach be to patients and doctors?
Source
Stat News
Opens original article in a new tab
Years ago, Archelle Georgiou helped squash prior auths at one of America's biggest health insurers.
(MedPage Today) -- Note that some links may require registration or subscription. Periods of bereavement were linked to higher risks of heart attack and stroke, associations that were amplified during the COVID pandemic. (JAMA Network Open) Utah...
Veradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more biotech news
Intellia disclosed that a single dose of its gene editing treatment dramatically reduced swelling attacks in patients with hereditary angioedema
